Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Kellanova
K
|
$54M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$51.7M |
| 3 |
Sensata Technologies
ST
|
$51.4M |
| 4 |
Oracle
ORCL
|
$47.9M |
| 5 |
Philip Morris
PM
|
$44.7M |
Top Sells
| 1 |
TW
TOWERS WATSON & CO COM STK CL A (DE)
TW
|
$61.6M |
| 2 |
Johnson & Johnson
JNJ
|
$53.3M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
$45.6M |
| 4 |
SNDK
SANDISK CORP
SNDK
|
$45.4M |
| 5 |
Netflix
NFLX
|
$43.4M |
Sector Composition
| 1 | Technology | 27.38% |
| 2 | Communication Services | 13.14% |
| 3 | Healthcare | 13.02% |
| 4 | Financials | 11.18% |
| 5 | Consumer Discretionary | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
B
226
DELISTED
Barnes Group Inc.
B
| $12.9M | 0.1% |
368,688
-10,674
| -3% | -$374K |
|
227
Trimble
TRMB
$19.2B
| $12.9M | 0.1% |
520,760
+11,913
| +2% | +$295K |
|
228
Seagate
STX
$40B
| $12.9M | 0.1% |
373,821
-26,821
| -7% | -$924K |
|
229
Hubbell
HUBB
$23.2B
| $12.7M | 0.1% |
120,122
+2,997
| +3% | +$318K |
|
230
KKR & Co
KKR
$121B
| $12.7M | 0.1% |
863,617
+4,602
| +0.5% | +$67.5K |
|
|
BXLT
231
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $12.6M | 0.1% |
311,002
-171,657
| -36% | -$6.94M |
|
232
Encompass Health
EHC
$12.6B
| $12.5M | 0.1% |
417,105
+10,478
| +3% | +$314K |
|
233
Essex Property Trust
ESS
$17.3B
| $12.4M | 0.1% |
52,868
-773
| -1% | -$181K |
|
234
Bristol-Myers Squibb
BMY
$96B
| $12.1M | 0.1% |
188,934
+9,996
| +6% | +$638K |
|
235
AbbVie
ABBV
$375B
| $12M | 0.1% |
210,701
+3,098
| +1% | +$177K |
|
236
Donaldson
DCI
$9.44B
| $11.9M | 0.1% |
373,759
-7,360
| -2% | -$235K |
|
237
IPG Photonics
IPGP
$3.56B
| $11.9M | 0.1% |
124,105
+3,081
| +3% | +$296K |
|
238
Axos Financial
AX
$5.13B
| $11.8M | 0.1% |
555,013
-16,041
| -3% | -$342K |
|
239
Globus Medical
GMED
$8.18B
| $11.8M | 0.1% |
496,975
-14,492
| -3% | -$344K |
|
240
T Rowe Price
TROW
$23.8B
| $11.8M | 0.1% |
160,621
+123,548
| +333% | +$9.08M |
|
|
MDSO
241
DELISTED
Medidata Solutions, Inc.
MDSO
| $11.7M | 0.1% |
302,419
-5,931
| -2% | -$230K |
|
242
Dorman Products
DORM
$5B
| $11.7M | 0.09% |
214,455
-6,221
| -3% | -$339K |
|
243
Pentair
PNR
$18.1B
| $11.6M | 0.09% |
317,147
+6,892
| +2% | +$251K |
|
244
Factset
FDS
$14B
| $11.5M | 0.09% |
76,137
-2,200
| -3% | -$333K |
|
245
Exponent
EXPO
$3.61B
| $11.4M | 0.09% |
445,304
+82,978
| +23% | +$2.12M |
|
|
HPP
246
Hudson Pacific Properties
HPP
$1.16B
| $11.3M | 0.09% |
391,745
+4,185
| +1% | +$121K |
|
247
Equinix
EQIX
$75.7B
| $11.3M | 0.09% |
34,032
+8,387
| +33% | +$2.77M |
|
|
EPAY
248
DELISTED
Bottomline Technologies Inc
EPAY
| $11.1M | 0.09% |
363,572
-10,491
| -3% | -$320K |
|
|
CCP
249
DELISTED
Care Capital Properties, Inc.
CCP
| $11.1M | 0.09% |
413,217
+128,060
| +45% | +$3.43M |
|
250
Yum! Brands
YUM
$40.1B
| $11.1M | 0.09% |
187,939
+23,994
| +15% | +$1.41M |
|